John Holyoake

John Holyoake currently serves as Vice President of Business Development at Xenon Pharmaceuticals Inc. since September 2023. With a robust background in investment banking, John has held various roles including Managing Director and Vice President at Bloom Burton & Co. from January 2012 to August 2023. John has also contributed to several biotech organizations, serving on the Board of Directors for companies such as Canadian Glycomics Network, Satellos Bioscience Inc., Triumvira Immunologics, and Appili Therapeutics. Academic achievements include a D.Phil in Computational Biochemistry and an M.Biochem in Biochemistry, both from the University of Oxford.